Siedlerstraße 7 | 68623 Lampertheim, Germany

info@zamann-pharma.com

This article explains how CSV Documentation supports GMP compliance in computerized systems, focusing on validation traceability, IQ OQ PQ documentation, and data integrity requirements aligned with FDA 21 CFR Part 11 and EU Annex 11 expectations.
This article provides a practical overview of GMP regulations in 2026, covering FDA 21 CFR 210/211, EU GMP guidelines EudraLex Volume 4, and WHO expectations. It explains inspection trends, audit readiness, and regulatory compliance gaps in pharmaceutical manufacturing systems.